Deciphera Pharmaceuticals, Inc. financial data

Symbol
DCPH on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Smith Street, Waltham, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Deciphera Pharmaceuticals, LLC (to 8/15/2017)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 434 % -19.9%
Quick Ratio 29.3 % +8.86%
Debt-to-equity 30.9 % +13.3%
Return On Equity -52.4 % -12.6%
Return On Assets -40 % -9.43%
Operating Margin -118 % +13.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 86.5M shares +10.1%
Common Stock, Shares, Outstanding 82.2M shares +4.65%
Entity Public Float 777M USD +22.2%
Common Stock, Value, Issued 821K USD +4.59%
Weighted Average Number of Shares Outstanding, Basic 87.4M shares +5.7%
Weighted Average Number of Shares Outstanding, Diluted 87.4M shares +5.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 175M USD +26.5%
Research and Development Expense 237M USD +21.5%
Costs and Expenses 381M USD +16.5%
Operating Income (Loss) -207M USD -9.23%
Nonoperating Income (Expense) 16.6M USD +103%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -195M USD -9.15%
Income Tax Expense (Benefit) 431K USD -40.3%
Net Income (Loss) Attributable to Parent -190M USD -4.8%
Earnings Per Share, Basic -2.21 USD/shares -1.84%
Earnings Per Share, Diluted -2.21 USD/shares -1.84%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 91.2M USD -20.4%
Marketable Securities, Current 223M USD -14.3%
Accounts Receivable, after Allowance for Credit Loss, Current 32.7M USD +45.7%
Inventory, Net 26M USD +1.97%
Other Assets, Current 1.39M USD
Assets, Current 350M USD -26.5%
Property, Plant and Equipment, Net 5.16M USD -20.8%
Operating Lease, Right-of-Use Asset 30.9M USD -12.8%
Assets 421M USD -23.3%
Accounts Payable, Current 19.5M USD -1.07%
Employee-related Liabilities, Current 7.92M USD -27.4%
Liabilities, Current 83.4M USD -0.58%
Operating Lease, Liability, Noncurrent 21.4M USD -14.3%
Liabilities 105M USD -3.72%
Accumulated Other Comprehensive Income (Loss), Net of Tax 98K USD
Retained Earnings (Accumulated Deficit) -1.47B USD -14.8%
Stockholders' Equity Attributable to Parent 316M USD -28.2%
Liabilities and Equity 421M USD -23.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -54.6M USD -10.4%
Net Cash Provided by (Used in) Financing Activities 522K USD -99.6%
Net Cash Provided by (Used in) Investing Activities 62.6M USD
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 82.2M shares +4.65%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22.2M USD +54.8%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 91.2M USD -20.4%
Deferred Tax Assets, Valuation Allowance 377M USD +15.2%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 377M USD +15.2%
Operating Lease, Liability 25.9M USD -11.1%
Payments to Acquire Property, Plant, and Equipment 146K USD -59.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -190M USD -4.89%
Lessee, Operating Lease, Liability, to be Paid 30.6M USD -13.5%
Property, Plant and Equipment, Gross 17.6M USD +4.93%
Operating Lease, Liability, Current 3.57M USD +8.27%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.94M USD +1.69%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.85M USD +1.72%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.75M USD -24.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.02M USD +1.68%
Deferred Tax Assets, Operating Loss Carryforwards 211M USD -1.37%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 431K USD -40.3%
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 3.14M USD +69.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.1M USD +1.63%
Operating Lease, Payments 4.77M USD +3.36%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 0 USD -100%
Current Federal Tax Expense (Benefit) 0 USD
Depreciation, Depletion and Amortization 450K USD -26%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 48.3M USD -3.84%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%